PFM
Parsec Financial Management’s Vertex Pharmaceuticals VRTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | $7.12M | Buy |
22,584
+126
| +0.6% | +$39.7K | 0.3% | 73 |
|
|
2022
Q4 | $6.49M | Buy |
22,458
+2,136
| +11% | +$617K | 0.29% | 77 |
|
|
2022
Q3 | $5.88M | Buy |
20,322
+7,531
| +59% | +$2.18M | 0.29% | 74 |
|
|
2022
Q2 | $3.6M | Buy |
12,791
+348
| +3% | +$98.1K | 0.17% | 94 |
|
|
2022
Q1 | $3.25M | Buy |
12,443
+6,226
| +100% | +$1.62M | 0.14% | 110 |
|
|
2021
Q4 | $1.37M | Sell |
6,217
-235
| -4% | -$51.6K | 0.06% | 151 |
|
|
2021
Q3 | $1.23M | Buy |
6,452
+2,304
| +56% | +$440K | 0.05% | 149 |
|
|
2021
Q2 | $836K | Buy |
4,148
+1,921
| +86% | +$387K | 0.04% | 160 |
|
|
2021
Q1 | $479K | Buy |
+2,227
| New | +$479K | 0.02% | 191 |
|